Physician profile
Maher M Nasser
NPI 1588762157
$3,097.59
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $869 · 2020: $607 · 2021: $577 · 2022: $649 · 2023: $396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $395.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $392.96 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $335.03 | 2019-2023 | |
| Amgen INC. | $333.19 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $248.94 | 2021-2023 | Verquvo |
| Medtronic, INC. | $217.56 | 2021-2023 | Corevalve Evolut R, Azure Xt Dr Mri Surescan |
| Janssen Pharmaceuticals, INC | $210.19 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $201.16 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $170.61 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $159.65 | 2021-2023 | Jardiance |
| Esperion Therapeutics, INC. | $153.05 | 2020-2023 | Nexletol |
| Pfizer INC. | $139.01 | 2019-2023 | |
| Arbor Pharmaceuticals, INC. | $125.46 | 2019-2021 | |
| Abbott Laboratories | $86.53 | 2021-2023 | Cardiomems |
| Heartflow, INC. | $83.33 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $72.11 | 2021-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $62.51 | 2022 | |
| Davol INC. | $26.33 | 2023 | Arista Ah Flexitip |
| Boston Scientific Corporation | $23.16 | 2020 | |
| Cardinal Health 200 LLC | $22.91 | 2019 | |
| Bardy Diagnostics, INC. | $20.00 | 2019 | |
| Chiesi USA, INC. | $13.90 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maher Nasser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.